Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-06

Clinical Trial Update: Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients [NA]

View source ↗

Summary

Trial update reporting prospective identification of predictive biomarkers for trabectedin efficacy across non-liposarcoma soft tissue sarcoma subtypes; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trabectedin (trabectedin)

Snippet

Sponsor: Institut Bergonié | Conditions: Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma | NA | Status: COMPLETED